Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.


Mayor Pannullo Opinion: Drug Importation Threatens Backbone of New Jersey’s Economy

The Honorable Joseph Pannullo

East Hanover, NJ, March 31, 2017In an op-ed published in The Record on March 22, East Hanover Mayor Joseph Pannullo wrote:

Millions of Americans’ lives are riding on the success of a few New Jersey companies.

Garden State pharmaceutical firms account for nearly 30 percent of all diabetes and heart disease treatments in development.  These two diseases alone kill hundreds of thousands of Americans each year.  And they’re driving U.S. healthcare costs through the roof.

Those treatments may never reach patients if some in Washington push forward with a plan to allow patients to import foreign prescription drugs.   Continue reading

Trump Health Care Plan Would Allow Drug Importation; Industry Opposes

Donald Trump 1Boston, MA, March 3, 2016 ― David Nather reports on STAT that Donald Trump released a health care plan Wednesday that includes common Republican ideas for replacing Obamacare but departs from conventional GOP policies in one major way: it would allow the reimportation of cheaper drugs from overseas.

Nather reports that this is the second time that front-runner Trump has embraced an idea to bring down drug costs that’s associated more with Democrats like Hillary Clinton and Bernie Sanders than with the party he’s trying to lead.

Trump has previously said that Medicare should be allowed to negotiate drug prices, which is also a centerpiece of the Clinton and Sanders plans to bring down drug prices.  That idea doesn’t appear anywhere in the health care plan he released Wednesday. Continue reading

PhRMA Applauds Federal Court Ruling on Maine Drug-Importation Law

Washington, DC, February 25, 2015 Pharmaceutical Research and Manufacturers of America (PhRMA) assistant general counsel, John Murphy, issued the following statement regarding a federal court ruling that invalidated an importation law in Maine.

“In September 2013, PhRMA, along with several Maine-based trade associations and individual pharmacists, filed a lawsuit against the state of Maine challenging a recently enacted law that permitted residents to personally import certain prescription medications from five countries around the globe. Continue reading

U.S. Senators Re-Introduce Bill to Allow Drug Importation from Canada

New York, NY, January 9, 2015 ― Pharmalot today reported that, in their latest bid to lower prescription drug costs, two U.S. Senators have re-introduced legislation that would allow Americans to purchase medicines from Canada.

This marks the second consecutive year that Amy Klobuchar (D-Minn.) and John McCain (R-Az.) have advocated the Safe and Affordable Drugs from Canada Act.

According to the Pharmalot report, the bill, if passed and signed into law, would permit Americans, who must have a valid prescription from a physician licensed in the U.S., to order up to a 90-day supply of medicines from a licensed Canadian pharmacy.  Prescription drugs would have to have the same active ingredients, dosage form, and potency as medicines that are approved by the FDA. Continue reading

U.S. Senators Revive Fight to Import Cheaper Prescriptions from Canada

Washington, DC, December 1, 2014 The Hill reported that United States Senators Amy Klobuchar (D-Minn.) and John McCain (R-Ariz.) are renewing their push for a bill to allow prescription drugs to be imported from Canada.

Klobuchar and McCain first introduced their bill in July, but it saw no action.  They now plan to revive the legislation in the lame-duck session,

It is illegal under federal law to buy any medication from overseas with a few exceptions; for instance, if a drug cannot be found in the U.S. Continue reading